Friday, September 17, 2021

COVID-19 vaccination: Nigeria yet to record any ‘adverse reactions’ – NPHCDA

Must read

Ibrahim Ramalan
Ibrahim Ramalan is a graduate of Mass Communications from the Ahmadu Bello University (ABU) Zaria. With nearly a decade-long, active journalism practice, Mr Ramalan has been able to rise from a cub reporter to the exalted position of an editor; first as Arts Editor with the Blueprint Newspapers before resigning in 2019; second and presently as an Associate Editor of the Daily Nigerian online newspaper. He can be reached via [email protected], or, or @McRamalan on Twitter.
- Advertisement -

The National Primary Health Care Development Agency, NPHCDA, has clarified that the country is yet to observe any ‘similar adverse reactions.’

READ ALSO:   Nigerian troops kill 220 bandits, arrest 892 suspects – DHQ

DAILY NIGERIAN reports that the Federal Government had kick-started the COVID-19 vaccination on Friday at the National Hospital, Abuja and, so far, some state governors had taken the delivery of some doses of the vaccine in their respective states.

The agency, in a statement released via its official handle @NphcdaNG, explained that all side effects reported by those who have been administered by the vaccine have been ‘mild’.

It explained that the agency is aware of precautionary concerns that have been raised regarding one specific batch of the AstraZeneca vaccine, namely ABV5300.

READ ALSO:   Buhari mourns Idriss Deby, says late Chadian President was a gallant leader

“We understand that investigations are being conducted to determine if the batch is in any way linked to an observed side effect.

“We are satisfied that the clinical evidence indicates the Oxford-AstraZeneca vaccine to be safe and effective.

While we await the outcome of the investigations, it is important to clearly state that Nigeria did not receive any doses from the batch of vaccines that is at issue.

READ ALSO:   VIDEO: Abducted Zamfara schoolgirls regain freedom

“Our assessment is in line with countries such as Spain and the UK who have indicated that they will continue to administer the vaccine because it remains an important tool to protect against COVID-19.

READ ALSO:   Schools reopen in Maiduguri for 2nd term academic session

“The safety of vaccines delivered to Nigeria is paramount to the Presidential Task Force on COVID-19. For this reason, it has enhanced multi-sectoral collaboration among stakeholders and technical entities such as the FMOH, NPHCDA, NAFDAC, WHO and UNICEF,” the agency added.

The agency encouraged Nigerians who are among those being prioritized in the current phase to continue their confidence and enthusiasm for the national vaccine program.

- Advertisement -

More articles


Please enter your comment!
Please enter your name here
READ ALSO:   Digital companies, liable to tax under new Finance Act — Osinbajo

- Advertisement -

Latest article

- Advertisement -